|
ALG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.970900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89089999999404E-05 |
| Normal-vs-Stage2 |
1.680630E-01 |
| Normal-vs-Stage3 |
6.716600E-01 |
| Normal-vs-Stage4 |
4.743600E-02 |
| Stage1-vs-Stage2 |
2.929600E-01 |
| Stage1-vs-Stage3 |
4.844400E-01 |
| Stage1-vs-Stage4 |
8.411600E-01 |
| Stage2-vs-Stage3 |
8.645200E-01 |
| Stage2-vs-Stage4 |
3.240200E-01 |
| Stage3-vs-Stage4 |
4.568600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.79019999999986E-05 |
| Normal-vs-AfricanAmerican |
1.294330E-02 |
| Normal-vs-Asian |
2.972000E-01 |
| Caucasian-vs-AfricanAmerican |
5.395000E-01 |
| Caucasian-vs-Asian |
8.433600E-01 |
| AfricanAmerican-vs-Asian |
7.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.985900E-04 |
| Normal-vs-Female |
7.855800E-02 |
| Male-vs-Female |
2.199200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.257200E-03 |
| Normal-vs-Extreme_Weight |
3.93659999999851E-05 |
| Normal-vs-Obese |
3.280600E-01 |
| Normal-vs-Extreme_Obese |
2.326000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.017600E-01 |
| Normal_Weight-vs-Obese |
3.166800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.857000E-01 |
| Extreme_Weight-vs-Obese |
2.162800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.518200E-01 |
| Obese-vs-Extreme_Obese |
7.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.632230E-02 |
| Normal-vs-Age(41-60Yrs) |
2.568000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.41940000000884E-06 |
| Normal-vs-Age(81-100Yrs) |
6.249700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.604000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.011200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.824800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.063920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.401700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.684400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.974700E-04 |
| Normal-VS-Type2 PRCC |
1.276850E-01 |
| Normal-VS-KIRP CIMP |
1.225920E-02 |
| Normal-VS-Unclassified PRCC |
1.191950E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.929600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.186200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.070600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.039800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.437400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.886000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.239400E-01 |
| Normal-vs-N1 |
7.907900E-02 |
| Normal-vs-N2 |
1.628870E-04 |
| N0-vs-N1 |
6.329800E-01 |
| N0-vs-N2 |
3.244600E-01 |
| N1-vs-N2 |
1.253380E-01 |
|
|
